Search

Your search keyword '"Lonneke Timmers"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Lonneke Timmers" Remove constraint Author: "Lonneke Timmers" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
17 results on '"Lonneke Timmers"'

Search Results

1. Tyrosine kinase inhibitor treatment discontinuation in chronic myeloid leukemia: patient views

2. Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients

Catalog

Books, media, physical & digital resources

3. Feasibility of and patients’ perspective on nilotinib dried blood spot self-sampling

4. Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib

5. Needs for information and reasons for (non-)adherence in chronic myeloid leukaemia: be aware of social activities disturbing daily routines

6. Pharmaceutical Care for Cancer Outpatients

7. PATIENTS' NEEDS AND WISHES REGARDING PHARMACEUTICAL CARE PROVIDED BY THE PHARMACIST FOR WOMEN TREATED WITH ADJUVANT ENDOCRINE THERAPY FOR BREAST CANCER

8. Patient satisfaction with information on oral anticancer agent use

9. Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer

10. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists

11. Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice

12. Adherence to oral anticancer agents: Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands

13. Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008

14. Adherence and patients' experiences with the use of oral anticancer agents

15. Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia

16. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions

17. The use of erlotinib in daily practice: a study on adherence and patients' experiences